<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-157714</identifier>
<setSpec>0003-3170</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Effectiveness of carotid endarterectomy for asymptomatic carotid stenosis in the statins era</dc:title>
<dc:description xml:lang="en">The benefit of carotid endarterectomy in asymptomatic patients is currently questioned, due to an observed reduction in stroke rate with current medical treatment. A review is carried out on the available evidence. The perioperative use of statins, better standardisation of surgical techniques, concentration of endarterectomy by surgeons with a higher surgical volume, and identification of high-risk patients, have led to a parallel decrease in post-endarterectomy stroke. An asymptomatic subpopulation has been identified with an increased risk of developing neurological events: severe carotid stenosis, rapid progression of stenosis, presence of silent hemispherical infarcts, micro-emboli in transcranial doppler, lower cerebrovascular reserve, and unstable plaques. The future of carotid endarterectomy in asymptomatic patients lies in the identification of lesions with increased risk of stroke and performing surgery with minimal morbidity and mortality. Imaging studies have rapidly progress, but better validation is required before changing current management guidelines (AU)</dc:description>
<dc:creator>Mariné, L</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El beneficio de la endarterectomía carotídea en pacientes asintomáticos es actualmente cuestionado por la reducción observada en la tasa de infarto cerebral con tratamiento médico actual. Se realiza una revisión de la evidencia disponible. El uso perioperatorio de estatinas, mejor estandarización de técnica quirúrgica, concentración de endarterectomías en cirujanos de mayor volumen quirúrgico e identificación de pacientes de mayor riesgo han permitido una disminución paralela de los infartos postendarterectomía. Se ha identificado una subpoblación asintomática con mayor riesgo de desarrollar eventos neurológicos: estenosis carotídeas severas, rápida progresión de estenosis, presencia de infartos hemisféricos silentes, microembolias en doppler transcraneal, menor reserva cerebrovascular y placas inestables. El futuro de la endarterectomía carotídea radica en la identificación de lesiones de mayor riesgo de infarto y realizar cirugía con mínima morbimortalidad. Los estudios de imágenes han mostrado un rápido avance, pero se requiere de mejor validación antes de cambiar las guías de manejo vigentes (AU)</dc:description>
<dc:source>Angiologia;68(6): 499-506, nov.-dic. 2016. ilus, tab</dc:source>
<dc:identifier>ibc-157714</dc:identifier>
<dc:title xml:lang="es">Vigencia de la endarterectomía carotídea para el tratamiento de estenosis asintomática en la era de las estatinas</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d30132^s22011</dc:subject>
<dc:subject>^d30132^s22045</dc:subject>
<dc:subject>^d33014^s22000</dc:subject>
<dc:subject>^d33014^s22044</dc:subject>
<dc:subject>^d30211^s22053</dc:subject>
<dc:subject>^d2583^s22044</dc:subject>
<dc:subject>^d30132^s22074</dc:subject>
<dc:subject>^d2583^s22053</dc:subject>
<dc:subject>^d30211^s22062</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d14190^s22045</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d14190^s22039</dc:subject>
<dc:subject>^d14863^s22039</dc:subject>
<dc:subject>^d30132^s22048</dc:subject>
<dc:subject>^d14863^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201612</dc:date>
</metadata>
</record>
</ibecs-document>
